We continue with the #INSIGHTSPodcast Series and in this episode, we focus on the healthcare sector and discuss opportunities and the market landscape using examples from the Accel portfolio. To talk about this exciting topic, We have Barath & Radhika, Principal & Sr Associate at Accel whose core focus investment areas are in Life sciences, Medtech and digital health.
On this podcast, we discuss the healthcare landscape in India using examples from the Accel portfolio and what to look for while building out a healthcare company from India :
Examples from Accel portfolio on problems being solved in healthcare for global markets
- Lifesciences
What is life sciences — the model of an IP led lifesciences company solving global problems - Mitra Biotech
Why did they choose to start in India?
The solution to an age old problem — How do you understand the effects of drugs on tumors without bombarding a patient with the drugs - Zumutor
Building a platform to develop molecules for improving drug delivery to cancer cells - Healthcare Delivery
The problems with the healthcare delivery in India
Moving care back to the home — counter intuitive insight and how Portea plugs the gaps in the delivery space - Digital health
Onco.com — using digital distribution to disrupt the current value chain and deliver better care for patients - Using AI to deliver healthcare in the diagnostics space — How sigtuple uses digital distribution and AI to deliver healthcare and diagnose correctly.
The Indian Advantage — Why healthcare is attractive in India
- Capital efficiency from being in India
3x-5x advantage in capital required from building from India
Talent, Infrastructure arbitrage from India — The Indian pharma story for next wave of lifesciences - Speeding things up — How India helps speed up development
The regulatory advantage — lesser regulations for initial development of drugs. Using the initial momentum and taking the drugs to more regulated markets for trials — the difficulty of trials in the Indian market - Examples where the thesis on cost and time plays out
The estimates from Axio — getting to market with 1/10th the capital and 60% of the time to get to market with a great product
Setting the standards in India so the product goes global — no compromise on quality
The healthcare business — things to consider while getting into the healthcare sector
- The trust process — building trust, and the time and effort it takes to build trust
- Importance of IP — having a good IP and using peer-reviewed publications for validation and marketing
- Patent portfolio and defensiblity of patents — defending incremental IP and not infringing existing patents, and filing patents to get it out in the world
- The team — building a team as the company grows, and the expertise required; the differences between life sciences, and non-life science businesses
- The Indian story — shift from communicable to chronic disease, infrastructure gap, mobile first country and the advantage technology provides in such an environment.
More Podcast from Radhika Ananth:
Understanding the Value of AI in Healthcare
We’re looking for the next generation of successful Indian marketplaces. If you’re an early-stage marketplace founder, apply now here or learn more about the #DecodingMarketplaces Startup Hunt.
We’d love to hear about your experiences with marketplaces. Let us share our learnings and build a better and stronger ecosystem. Write to us at seedtoscale@accel.com to be a part of the Accel family.
Subscribe to SeedToScale
/subscribe to get the latest stories from SeedToScale/
AI Powered Summary
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.
We’re building Passionfroot 1, an operating system for creators to manage their business.
We’re based in Europe and raised our $ 3.4m pre-seed round from Creandum and US angels such as Vlad (Webflow) and creators like Ali Abdaal.As we’re creating a new category and as the creator economy is global and mostly online, we’re building from Day 1 a global company and product that helps creators monetize around the world.
This brings a lot of complexities especially in terms of payments and taxes as our early users are based both in Europe and the US and deal with cross-border transactions.What are Do’s and Dont’s for European startups who have a global ambition and build products for a global customer base from Day 1. Anything you would do differently?
Thanks @pjbouten! Love how you’ve thought about incrementally shaping a category with a focus on product and service, and only then thinking about getting the message out there vs the other way around.
And totally agree on the distinctions and overlaps both self-serve and enterprise motions share.
Thanks, PJ, for taking the time to address questions from the great vantage of shaping Showpad into a global, enterprise SaaS brand!